Covidien Ventures
6
26M
6
2
3
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Mansfield. The fund was located in North America if to be more exact in United States. Covidien Ventures appeared to be a CVC structure as part of the corporation.
The fund is constantly included in less than 2 deals per year. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2015. The high activity for fund was in 2011. This Covidien Ventures works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Covidien Ventures, startups are often financed by Three Arch Partners, Split Rock Partners, SV Health Investors. The meaningful sponsors for the fund in investment in the same round are SV Health Investors, Topspin Partners, Three Arch Partners. In the next rounds fund is usually obtained by New Enterprise Associates, Morgenthaler Ventures, Medtronic.
Among the most popular fund investment industries, there are Pharmaceutical, Health Care. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline SetPoint Medical, ValenTx, Entellus Medical
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 2
- Exits
- 3
- Investments by industry
- Health Care (6)
- Medical Device (5)
- Biotechnology (4)
- Medical (2)
- Therapeutic Devices (1) Show 5 more
- Investments by region
-
- United States (6)
- Peak activity year
- 2011
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Avg. valuation at time of investment
- 50M
- Group Appearance index
- 0.83
- Avg. company exit year
- 16
- Avg. multiplicator
- 1.66
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Nevro | 07 Mar 2013 | Biotechnology, Health Care, Health Diagnostics, Pharmaceutical | Late Stage Venture | 48M | United States, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.